Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lawrence Long"'
Autor:
Kathryn L. Dovel, Santhi Hariprasad, Julie Hubbard, Morna Cornell, Khumbo Phiri, Augustine Choko, Rachel Abbott, Risa Hoffman, Brooke Nichols, Sundeep Gupta, Lawrence Long
Publikováno v:
Tropical Medicine & International Health.
Autor:
Matthew P. Fox, Mhairi Maskew, Lawrence Long, Alana T. Brennan, Timothy Heeren, Ian Sanne, Rachael Bonawitz
Publikováno v:
Trop Med Int Health
INTRODUCTION In April 2010, tenofovir and abacavir replaced stavudine in public sector first-line antiretroviral therapy (ART) for children under 20 years old in South Africa. The association of both abacavir and tenofovir with fewer side effects and
Autor:
Francesca Conradie, Mary-Ann Davies, Matthew P. Fox, Mhairi Maskew, Alana T. Brennan, Ian Sanne, Jacob Bor, Lawrence Long
Publikováno v:
Tropical Medicine & International Health. 22:241-251
Objective Using data from four public sector clinics in South Africa, we sought to investigate provider- and patient-level outcomes, to understand how the 2012 tenofovir stock shortage affected the HIV care and monitoring of ART patients. Methods Pro
Autor:
Denise Evans, Kate Shearer, Lawrence Long, Ian Sanne, Rebecca Berhanu, Julia Rohr, Matthew P. Fox, Liudmyla van den Berg, Faith Moyo
Publikováno v:
Tropical Medicine & International Health
Objectives To report predictors of outcomes of second-line ART for HIV treatment in resource-limited settings. Methods All adult ART-naive patients who initiated standard first-line treatment between April 2004-February 2012 at four public-sector hea
Publikováno v:
Trop Med Int Health
Objective In April 2010, South Africa replaced stavudine with tenofovir in first-line antiretroviral therapy (ART) despite tenofovir's higher cost. We examined treatment outcomes over 24 months amongst patients initiated on tenofovir-based vs. stavud
Autor:
Kate Shearer, Sydney Rosen, Kathryn Schnippel, Ian Sanne, Ebrahim Variava, Lawrence Long, Neil A. Martinson
Publikováno v:
Tropical Medicine & International Health. 18:109-116
In South Africa, patients with multi-drug-resistant tuberculosis (MDR-TB) are hospitalised from MDR-TB treatment initiation until culture conversion. Although MDR-TB accounts for3% of incident TB in South Africa, 55% of the public sector TB budget is